Allianz Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-34,670
| Closed | -$2.33M | – | 1720 |
|
|
2022
Q2 | $2.33M | Buy |
34,670
+19,555
| +129% | +$1.31M | ﹤0.01% | 1257 |
|
|
2022
Q1 | $1.24M | Sell |
15,115
-8,312
| -35% | -$684K | ﹤0.01% | 1496 |
|
|
2021
Q4 | $3.44M | Sell |
23,427
-8,994
| -28% | -$1.32M | ﹤0.01% | 1234 |
|
|
2021
Q3 | $5.74M | Buy |
32,421
+8,747
| +37% | +$1.55M | ﹤0.01% | 1063 |
|
|
2021
Q2 | $3.82M | Buy |
23,674
+143
| +0.6% | +$23.1K | ﹤0.01% | 1116 |
|
|
2021
Q1 | $4.03M | Sell |
23,531
-1,713
| -7% | -$293K | ﹤0.01% | 1062 |
|
|
2020
Q4 | $5.54M | Buy |
25,244
+2,814
| +13% | +$618K | 0.01% | 996 |
|
|
2020
Q3 | $3.73M | Buy |
22,430
+123
| +0.6% | +$20.4K | ﹤0.01% | 1057 |
|
|
2020
Q2 | $2.55M | Buy |
22,307
+11,921
| +115% | +$1.36M | ﹤0.01% | 1204 |
|
|
2020
Q1 | $799K | Sell |
10,386
-23,321
| -69% | -$1.79M | ﹤0.01% | 1510 |
|
|
2019
Q4 | $4.34M | Buy |
33,707
+24,966
| +286% | +$3.22M | ﹤0.01% | 1224 |
|
|
2019
Q3 | $697K | Buy |
8,741
+78
| +0.9% | +$6.22K | ﹤0.01% | 1791 |
|
|
2019
Q2 | $892K | Sell |
8,663
-26,701
| -76% | -$2.75M | ﹤0.01% | 1784 |
|
|
2019
Q1 | $2.59M | Buy |
+35,364
| New | +$2.59M | ﹤0.01% | 1483 |
|